The purpose of this study is to learn more about the safety, effectiveness and tolerability of the study drug called Benfotiamine, to determine whether it delays or slows the progression of the symptoms of early Alzheimer’s disease.
Active, recruiting
217-545-3013
Related Profiles
skohlrus@siumed.edu
Stephanie Kohlrus